ABT vs GEV · P/E 25, rev $44.33B vs P/E 28, rev $38.07B
Abbott Laboratories (ABT) versus GE Vernova LLC (GEV) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
GE Vernova LLC (GEV) is a specialty industrial machinery company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported GEV revenue for 2025-12-31 was $38.07B. Net income was $4.88B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. GEV currently screens at market cap $260.21B and trailing P/E 28.3.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. GEV currently screens at market cap $260.21B and trailing P/E 28.3.
Not investment advice. Open the ABT and GEV stock pages for the full models.
Not investment advice.